Clarity Pharmaceuticals
Michelle joined the Company in June 2018 and is the Company’s Director of Clinical Operations.
Michelle has over 20 years of experience spanning across nuclear medicine/PET and pharmaceutical industries both in Australia and internationally. Prior to joining the Company, Michelle held the position of Head of International Clinical Research Operations at Novartis Australia, a global pharmaceutical company, leading a multi-disciplinary, high performing team of over 35 associates responsible for end-to-end clinical trial execution.
Michelle holds a Bachelor of Applied Science in Medical Radiation Technology (Nuclear Medicine) from the University of Sydney.
Clarity Pharmaceuticals
Clarity Pharmaceuticals is a personalized medicine company focused on the treatment of serious disease.